Shelley B Thunen Rx Sight, Inc. (RXST) insider trading activity

RXST Quotes by TradingView

Shelley B Thunen is of RxSight, Inc.. Currently has a direct ownership of 38,354 shares of RXST, which is worth approximately $558,434. The most recent transaction as insider was on Apr 14, 2025, when has been sold 7,792 shares (Common Stock) at a price of $4.34 per share, resulting in proceeds of $33,817. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.4K
25.99% 3M change
180.14% 12M change
Total Value Held $558,434

Shelley B Thunen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 14 2025
BUY
Exercise of conversion of derivative security
$33,817 $4.34 p/Share
7,792 Added 16.89%
38,354 Common Stock
Oct 01 2024
SELL
Open market or private sale
$730,500 $48.7 p/Share
15,000 Reduced 33.01%
30,443 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
$240,000 $16.0 p/Share
15,000 Added 24.82%
45,443 Common Stock
Jul 15 2024
BUY
Exercise of conversion of derivative security
$71,631 $4.34 p/Share
16,505 Added 35.16%
30,443 Common Stock
Jul 01 2024
SELL
Open market or private sale
$589,500 $58.95 p/Share
10,000 Reduced 41.77%
13,938 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
$156,000 $15.6 p/Share
10,000 Added 29.47%
23,938 Common Stock
May 01 2024
SELL
Open market or private sale
$528,600 $52.86 p/Share
10,000 Reduced 41.77%
13,938 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
$159,853 $15.6 p/Share
10,247 Added 29.98%
23,938 Common Stock
Mar 01 2024
SELL
Open market or private sale
$561,200 $56.12 p/Share
10,000 Reduced 42.21%
13,691 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
$156,000 $15.6 p/Share
10,000 Added 29.68%
23,691 Common Stock
Feb 06 2024
SELL
Open market or private sale
$753,586 $47.47 p/Share
15,875 Reduced 53.69%
13,691 Common Stock
Feb 06 2024
BUY
Exercise of conversion of derivative security
$237,331 $14.95 p/Share
15,875 Added 34.94%
29,566 Common Stock
Feb 05 2024
SELL
Open market or private sale
$429,057 $47.02 p/Share
9,125 Reduced 39.99%
13,691 Common Stock
Feb 05 2024
BUY
Exercise of conversion of derivative security
$154,641 $9.65 p/Share
16,025 Added 41.26%
22,816 Common Stock
Jan 26 2024
SELL
Open market or private sale
$1,496,778 $47.11 p/Share
31,772 Reduced 82.39%
6,791 Common Stock
Jan 26 2024
BUY
Exercise of conversion of derivative security
$352,201 $9.71 p/Share
36,272 Added 48.47%
38,563 Common Stock
Jan 02 2024
SELL
Open market or private sale
$392,000 $39.2 p/Share
10,000 Reduced 81.36%
2,291 Common Stock
Jan 02 2024
BUY
Exercise of conversion of derivative security
$156,000 $15.6 p/Share
10,000 Added 44.86%
12,291 Common Stock
Dec 15 2023
SELL
Open market or private sale
$787,000 $39.35 p/Share
20,000 Reduced 89.72%
2,291 Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
$312,000 $15.6 p/Share
20,000 Added 47.29%
22,291 Common Stock

Also insider at

PMGM
Priveterra Acquisition Corp. Financial Services
Director
GRPH
Graphite Bio, Inc. Healthcare
Director
SBT

Shelley B Thunen

Aliso Viejo, CA

Track Institutional and Insider Activities on RXST

Follow RxSight, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXST shares.

Notify only if

Insider Trading

Get notified when an Rx Sight, Inc. insider buys or sells RXST shares.

Notify only if

News

Receive news related to RxSight, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXST